PsychoGenics Receives $3M SBIR Grant from NIMH to Advance AI-Enabled Drug Discovery
PsychoGenics offers a comprehensive suite of capabilities, including standard behavioral testing, electrophysiology, translational EEG, molecular biology, microdialysis, and quantitative immunohistochemistry.